A recent study shows that MAPK6/ERK3 exerts its tumor suppressor function by inhibiting cell cycle progression (Julien et al., 2003) and proliferation and invasion of melanoma (Chen et al., 2019a). Here, MAPK6 is linked to neoplasm.